Ah yes because that's never been done before by Cynata or Ross has it ??? Ross frequently pays for advertorials - here's some examples and of course the last report is fun to read - predictions for CYP of a MC of $408 million or $2.95 per share .... how's that working out almost 2 years later with a MC almost one tenth that size ....
"This report has been commissioned by Cynata Therapeutics Limited and prepared and issued by Chris Kallos of MST Access in consideration of a fee payable by Cynata Therapeutics Limited. "
Enjoy your day
https://files.cynata.com/663/MST-Access---CYP-Update---19Nov21.pdf
https://files.cynata.com/662/MST-Access---CYP-Initiation-Report---11Jun21-(002).pdf
Oh and this spiel worked out great in another edition from this same organisation Ross frequently shells out cheques to ....
"MST Access’s healthcare and #biotech equities analyst Chris Kallos, CFA has valued Cynata at A$408m or A$2.95 per share"
https://www.mstfinancial.com.au/blo...pasx-is-unlocking-the-potential-of-stem-cells
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |